IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ABATI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.785
EU - Europa 4.500
NA - Nord America 4.246
SA - Sud America 627
AF - Africa 99
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.905
CN - Cina 1.749
IT - Italia 1.245
SG - Singapore 894
GB - Regno Unito 669
DE - Germania 519
BR - Brasile 439
JP - Giappone 351
HK - Hong Kong 346
SE - Svezia 309
VN - Vietnam 293
FR - Francia 285
ES - Italia 279
BD - Bangladesh 276
IN - India 257
RU - Federazione Russa 213
CA - Canada 180
NL - Olanda 154
TR - Turchia 118
FI - Finlandia 112
MX - Messico 105
KR - Corea 102
IE - Irlanda 90
PT - Portogallo 90
ID - Indonesia 85
TW - Taiwan 84
GR - Grecia 82
PL - Polonia 72
BE - Belgio 69
AU - Australia 66
DK - Danimarca 59
CH - Svizzera 54
AR - Argentina 50
AT - Austria 40
CL - Cile 40
NO - Norvegia 36
CO - Colombia 35
UA - Ucraina 29
IR - Iran 28
PK - Pakistan 27
EC - Ecuador 26
IL - Israele 24
RO - Romania 24
PH - Filippine 22
CI - Costa d'Avorio 20
CZ - Repubblica Ceca 20
PE - Perù 20
HU - Ungheria 17
PR - Porto Rico 16
ZA - Sudafrica 16
MY - Malesia 14
IQ - Iraq 13
EG - Egitto 11
CY - Cipro 10
JO - Giordania 10
TH - Thailandia 10
TN - Tunisia 10
KG - Kirghizistan 9
PY - Paraguay 8
DZ - Algeria 7
GE - Georgia 7
LU - Lussemburgo 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
MA - Marocco 6
NI - Nicaragua 6
NP - Nepal 6
SA - Arabia Saudita 6
GH - Ghana 5
KE - Kenya 5
LB - Libano 5
MO - Macao, regione amministrativa speciale della Cina 5
PA - Panama 5
QA - Qatar 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
IS - Islanda 4
LK - Sri Lanka 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
SC - Seychelles 4
AD - Andorra 3
BO - Bolivia 3
CU - Cuba 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
KZ - Kazakistan 3
LT - Lituania 3
LV - Lettonia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
GT - Guatemala 2
HN - Honduras 2
MU - Mauritius 2
SN - Senegal 2
Totale 14.306
Salva come PNG Salva come JPEG
Città #
Singapore 520
Ashburn 423
Southend 305
Dallas 268
Milan 263
Hong Kong 253
Beijing 205
Hefei 203
San Jose 203
Chandler 181
Fairfield 155
Frankfurt am Main 136
Los Angeles 132
New York 119
Council Bluffs 105
Ho Chi Minh City 93
Houston 93
Tokyo 92
Santa Clara 87
Redwood City 86
Shanghai 85
Helsinki 81
Rome 80
Cambridge 77
Dublin 76
Bengaluru 75
Hanoi 72
Wilmington 72
Guangzhou 70
Moscow 69
Boardman 67
São Paulo 64
Ann Arbor 61
Seattle 61
Woodbridge 61
Nanjing 58
Jakarta 57
Mumbai 50
Princeton 48
Munich 47
Seoul 43
Toronto 43
Istanbul 42
Wuhan 42
Buffalo 41
London 40
Madrid 38
Chicago 36
Phoenix 36
Naples 35
Sheffield 35
Brussels 33
Rio de Janeiro 33
Hangzhou 32
Lauterbourg 32
Shenzhen 31
Cardiff 30
Barcelona 28
Changsha 28
Dearborn 28
Florence 27
Jinan 27
Grafing 25
Taichung 25
Warsaw 25
Berlin 24
Columbus 24
Philadelphia 24
Tianjin 24
Turin 24
Athens 23
Lisbon 23
Mexico City 23
Montreal 23
Valencia 23
Paris 22
Ankara 21
Palermo 21
Santiago 21
The Dalles 21
Abidjan 20
Andover 20
Denver 20
Romola 20
Stavanger 20
Atlanta 19
Ottawa 19
Taipei 19
Utrecht 19
Bari 18
Bologna 18
Boylston 18
Chengdu 18
Chongqing 18
Des Moines 18
Genoa 18
Verona 18
Belo Horizonte 17
Boston 17
Fuzhou 17
Totale 6.800
Salva come PNG Salva come JPEG
Nome #
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS) 4.758
Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy 458
Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis 449
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 425
Herpes Simplex virus type 2 myeloradiculitis with a pure motor presentationin a liver transplant recipient 367
Nusinersen treatment and cerebrospinal fluid neurofilaments : An explorative study on Spinal Muscular Atrophy type 3 patients 358
Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature 356
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? 356
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 352
Neural stem cell transplantation for neurodegenerative diseases 348
Central nervous system involvement in common variable immunodeficiency: A case of acute unilateral optic neuritis in a 26 -year-old Italian Patient 339
Ophthalmoplegia due to Miller Fisher syndrome in a patient with myasthenia gravis 331
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic 305
Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature 298
Charcot-Marie-Tooth disease type 2F associated with biallelic HSPB1 mutations 296
Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease? 280
Animal Models of CMT2A: State-of-art and Therapeutic Implications 277
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases 270
In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells 255
Shaping the Neurovascular Unit Exploiting Human Brain Organoids 254
Pregnancy outcomes in women with spinal muscular atrophy : a review 231
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art 227
Adeno-Associated Virus (AAV)-mediated gene therapy for Duchenne muscular dystrophy : the issue of transgene persistence 227
Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy 214
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy 211
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples 183
Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study 179
Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy 175
Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy 165
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives 160
IN VIVO AND IN VITRO EVALUATION OF THE COMBINATION OF RNA INTERFERING AND GENE THERAPY FOR TREATING MITOFUSIN2-RELATED DISEASES 159
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A 158
A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region 149
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 141
Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments? 137
Charcot-Marie-Tooth type 2A in vivo models: Current updates 135
A rare association of Guillain-Barré syndrome/Miller-Fisher syndrome overlap syndrome and Herpes Simplex Virus Type 1 infection: trigger or exacerbating factor? 135
Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction : a trembling balance 126
Perspectives on hiPSC-derived muscle cells as drug discovery models for muscular dystrophies 110
Education Research: Effect of the COVID-19 pandemic on neurology trainees in Italy 91
Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models 55
Case Report: Acute onset hemiparesis in a young man: do not miss Crohn's disease 47
Investigating the role of serum NfL, FGF21, NCAM1 and GDF15 as disease biomarkers for Charcot-Marie-Tooth type 2A 25
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease 11
Totale 14.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.363 69 90 86 163 119 118 113 86 168 106 82 163
2022/20231.447 177 118 82 99 93 163 90 134 135 98 143 115
2023/20242.039 119 156 191 178 229 128 138 188 129 152 194 237
2024/20252.911 199 225 174 254 233 186 225 265 236 267 291 356
2025/20265.038 424 459 584 396 310 291 697 196 444 298 518 421
2026/20277 7 0 0 0 0 0 0 0 0 0 0 0
Totale 14.583